InflaRx N.V. logo
InflaRx N.V. IFRX
$ 1.05 -4.55%
report update icon

Quarterly report 2018-Q4
added 11-06-2026

InflaRx N.V. Interest Expense | IFRX

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.
Includes:
  • Interest on bank loans
  • Interest on corporate bonds
  • Interest on leases
  • Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense InflaRx N.V.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.69 K 885 16.5 K 23.3 K 10.7 K 18.7 K - - - - - - - - -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
23.3 K 885 12.1 K

Quarterly Interest Expense InflaRx N.V.

2025-Q4 2025-Q2 2024-Q4 2024-Q2 2023-Q4 2023-Q2 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
2.69 K - 885 - 16.5 K 363 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum Minimum Average
16.5 K 363 5.12 K

Interest Expense of other stocks in the Biotechnology industry

Issuer Interest Expense Price % 24h Market Cap Country
Sesen Bio Sesen Bio
SESN
296 K - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
-408 K - - $ 26.8 M usaUSA
Trean Insurance Group Trean Insurance Group
TIG
3.27 M - - $ 316 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
-3 K - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
-16 K - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
290 K - - $ 13 M usaUSA
Brickell Biotech Brickell Biotech
BBI
5 K - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
-77 K - - $ 8.42 M usaUSA
Merus N.V. Merus N.V.
MRUS
1.06 M - - $ 5.78 B niderlandNiderland
Annexon Annexon
ANNX
57 K $ 3.11 -8.94 % $ 482 M usaUSA
Galapagos NV Galapagos NV
GLPG
1.03 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
31 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
294 K - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
741 K $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
-36 K $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
54 K - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
683 K - - $ 35.3 M usaUSA
Axcella Health Axcella Health
AXLA
3.02 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
1.2 M - - $ 24.2 M usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
14 M - -0.04 % $ 2.62 B usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
7 K - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
4.67 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
340 K - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
3 K - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
7.27 K - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
2.13 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
-1.72 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
-994 K - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
179 K - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
5.81 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
-47 K - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
12.7 K - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
-27.9 K - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
1.24 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
20.9 K - 31.87 % $ 1.61 M usaUSA